A retrospective observational pilot study on the effects of dexmedetomidine on neurological outcomes after aneurysmal subarachnoid hemorrhage

•Dexmedetomidine may be associated with alterations in outcomes for patients with aneurysmal subarachnoid hemorrhages.•Dexmedetomidine infusions in patients with aneurysmal subarachnoid hemorrhages prior to vasospasm onset was not associated with significant neurological outcomes.•Dexmedetomidine ha...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical anesthesia 2021-02, Vol.68, p.110106-110106, Article 110106
Main Authors: Esfahani, Kamilla, Lacomis, Christopher, Dunn, Lauren K., Chen, Ching-Jen, Zuo, Zhiyi, Naik, Bhiken I.
Format: Article
Language:English
Subjects:
Anesthesia
Aneurysms
Diabetes
Hypertension
Intensive care
Ischemia
Stroke
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Dexmedetomidine may be associated with alterations in outcomes for patients with aneurysmal subarachnoid hemorrhages.•Dexmedetomidine infusions in patients with aneurysmal subarachnoid hemorrhages prior to vasospasm onset was not associated with significant neurological outcomes.•Dexmedetomidine has several neurological benefits and should be studied further in subarachnoid hemorrhage patients.
ISSN:0952-8180
1873-4529
DOI:10.1016/j.jclinane.2020.110106